Send us Feedback

STAAR Surgical Company (STAA)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

STAA » Topics » Income Taxes

These excerpts taken from the STAA 10-K filed Mar 12, 2008.

Income Taxes

The Company recognizes deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of the Company’s assets and liabilities along with net operating loss and credit carryforwards in accordance with SFAS No. 109 “Accounting for Income Taxes.” A valuation allowance is recognized if, based on the weight of available evidence, it is more likely than not that some portion

F-12

TABLE OF CONTENTS

STAAR SURGICAL COMPANY AND SUBSIDIARIES
  
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Years Ended December 28, 2007 and December 29, 2006

Note 1 — Significant Accounting Policies  – (continued)

or all of the deferred tax asset may not be realized. The impact on deferred taxes of changes in tax rates and laws, if any, are applied to the years during which temporary differences are expected to be settled and reflected in the financial statements in the period of enactment.

Income Taxes



The Company recognizes deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of the Company’s assets and liabilities along with net operating loss and credit carryforwards in accordance with SFAS No. 109 “Accounting for Income Taxes.” A valuation allowance is recognized if, based on the weight of available evidence, it is more likely than not that some portion





F-12









TABLE OF CONTENTS



STAAR SURGICAL COMPANY AND SUBSIDIARIES
  
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Years Ended December 28, 2007 and December 29, 2006



Note 1 — Significant Accounting Policies  – (continued)



or all of the deferred tax asset may not be realized. The impact on deferred taxes of changes in tax rates and laws, if any, are applied to the years during which temporary differences are expected to be settled and reflected in the financial statements in the period of enactment.



These excerpts taken from the STAA 10-K filed Feb 7, 2008.
Income Taxes
 
The Company recognizes deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of the Company’s assets and liabilities along with net operating loss and credit carryforwards. A valuation allowance is recognized if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax asset may not be realized. The impact on deferred taxes of changes in tax rates and laws, if any, are applied to the years during which temporary differences are expected to be settled and reflected in the financial statements in the period of enactment.
 
Income
Taxes


 



The Company recognizes deferred tax assets and liabilities for
temporary differences between the financial reporting basis and
the tax basis of the Company’s assets and liabilities along
with net operating loss and credit carryforwards. A valuation
allowance is recognized if, based on the weight of available
evidence, it is more likely than not that some portion or all of
the deferred tax asset may not be realized. The impact on
deferred taxes of changes in tax rates and laws, if any, are
applied to the years during which temporary differences are
expected to be settled and reflected in the financial statements
in the period of enactment.


 




This excerpt taken from the STAA 10-K filed Mar 29, 2007.
Income Taxes
 
The Company recognizes deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of the Company’s assets and liabilities along with net operating loss and credit carryforwards. A valuation allowance is recognized if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax asset may not be realized. The impact on deferred taxes of changes in tax rates and laws, if any, are applied to the years during which temporary differences are expected to be settled and reflected in the financial statements in the period of enactment.
 

EXCERPTS ON THIS PAGE:

10-K (2 sections)
Mar 12, 2008
10-K (2 sections)
Feb 7, 2008
10-K
Mar 29, 2007

RELATED TOPICS for STAA:

"Income Taxes" elsewhere:

Adolor (ADLR)
Alnylam Pharmaceuticals (ALNY)
Allos Therapeutics (ALTH)
Anika Therapeutics (ANIK)
Array BioPharma (ARRY)
AtriCure (ATRC)
AVANIR Pharmaceuticals (AVNR)
BioLase Technology (BLTI)
Cadence Pharmaceuticals (CADX)
Dyax (DYAX)
Heska (HSKA)
Endo Pharmaceuticals Solutions Inc. (IDEV)
Kensey Nash (KNSY)
LeMaitre Vascular (LMAT)
Medarex (MEDX)
Monogram Biosciences (MGRM)
Memry (MRY)
Matrixx Initiatives (MTXX)
MWI Veterinary Supply (MWIV)
Natural Alternatives International (NAII)
Nektar Therapeutics (NKTR)
Nyer Medical Group (NYER)
Owens & Minor (OMI)
Orchid Cellmark (ORCH)
Oscient Pharmaceuticals (OSCI)
OraSure Technologies (OSUR)
Patterson Companies (PDCO)
PHC (PHC)
Palomar Medical Technologies (PMTI)
PSS World Medical (PSSI)
RELIV INTERNATIONAL INC (RELV)
Repligen (RGEN)
Rochester Medical (ROCM)
SenoRx (SENO)
Span-America Medical Systems (SPAN)
SurModics (SRDX)
Astex Pharmaceuticals, Inc (SUPG)
Tongjitang Chinese Medicines Company (TCM)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki